Apple Inc. Remains a Top Holding for Aspiriant LLC

Institutional investor trims stake in iPhone maker but keeps it as 10th largest position

Apr. 18, 2026 at 7:21am

Got story updates? Submit your updates here. ›

A high-contrast black and white close-up image of the internal components and circuitry of an Apple iPhone, conveying the complex industrial design and engineering that powers the company's iconic mobile devices.An extreme close-up of the intricate inner workings of an Apple iPhone, highlighting the brand's engineering prowess and the technological infrastructure behind its popular mobile devices.Cupertino Today

Aspiriant LLC, an institutional investor, reduced its holdings in Apple Inc. (NASDAQ:AAPL) by 3.3% in the fourth quarter, according to a recent SEC filing. However, Apple remains the firm's 10th largest position, making up 2.2% of its overall portfolio.

Why it matters

Apple is one of the most widely held and closely watched stocks among institutional investors. This filing provides insight into how a major investment firm is managing its exposure to the tech giant, which can signal broader trends in the market's sentiment towards the company.

The details

Aspiriant LLC now owns 283,200 shares of Apple stock, down from 292,895 shares in the previous quarter. The firm cited the 3.3% reduction in its Apple holdings, selling 9,695 shares during the period. Despite the trim, Apple continues to be a significant position for Aspiriant, ranking as its 10th largest holding and accounting for 2.2% of its total portfolio.

  • Aspiriant LLC filed its 13F report for the fourth quarter of 2025 on April 18, 2026.

The players

Aspiriant LLC

An institutional investment firm that manages over $15 billion in assets for high-net-worth individuals and families.

Apple Inc.

A multinational technology company headquartered in Cupertino, California, known for its consumer electronics, software, and digital services including the iPhone, iPad, Mac, and App Store.

Got photos? Submit your photos here. ›

The takeaway

Aspiriant's continued sizable stake in Apple suggests the firm remains bullish on the tech giant's long-term prospects, even as it trims its exposure slightly. This filing provides a window into how one major institutional investor is navigating the Apple investment amid broader market conditions.